Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma

Table 1

Patients’ demographics, .

Age (range)	56.4 (23.4–85.4)
Tumor size (range)	9 (2–30)
Number of metastatic sites (range)	2 (1–8)
Presentation status
Primary disease	132 (61)
Metastatic disease	83 (39)
Gender
Female	135 (63)
Male	80 (37)
Primary tumor size
<5 cm	34 (16)
5–10 cm	81 (38)
>10 cm	80 (37)
Unknown primary	10 (5)
Known primary, unknown size	10 (5)
KPS
60	2 (1)
70	8 (4)
80	46 (21)
90	65 (30)
100	22 (10)
Unknown	72 (33)
Primary site
A/P or RP	151 (70)
Extremity	45 (21)
Trunk	9 (4)
Unknown primary	10 (5)
Margins
Negative	95 (44)
Positive	45 (21)
Gross disease	3 (1)
N/A—no surgery	47 (22)
Unknown	25 (12)
Grade
Low	7 (3)
Intermediate	5 (2)
High	176 (82)
Unknown	27 (14)
Depth
Superficial	5 (2)
Deep	196 (91)
Unknown	14 (7)
Number of metastatic sites
<3	144 (67)
≥3	71 (33)
Lung metastases
No	102 (47)
Yes	113 (53)
Liver metastases
No	159 (74)
Yes	56 (26)

Numbers may not add to 100 due to rounding. KPS: Karnofsky Performance Status; A/P: abdomen/pelvis, RP: retroperitoneal; and N/A: not applicable.